1.
de Portu S, Mantovani LG, Olivieri I. Cost-utility analysis of abatacept in rheumatoid arthritis in Italy. FE [Internet]. 2008 Mar. 15 [cited 2025 Jul. 23];9(1):19-26. Available from: https://provafe.seedstm.com/index.php/FE/article/view/212